VANCOUVER, BC, Sept. 29, 2022 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) ( OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in the Cantor Neurology & Psychiatry Conference to be held at The Ritz-Carlton in San Francisco on October 6-7, 2022.


Previous articlePT360 – Stephanie Wang – Kanna: Love and Wholeness Through Nature’s Alternative to MDMA
Next articlePsyence Group Completes Export of Psilocybin Mushrooms to Portugal